1014-25: Addicted to the Perfect Body: The Use and Misuse of the GLP-1 Receptor Agonists

GLP-1 use has become a multi-billion dollar business with non-FDA approved compounded drugs being offered at reduced rates, but at what cost? This presentation will explore these questions and the approved indications, use, risk management and potential benefits, and how PMH nurses can help patients navigate these issues.

Presenters:  Julie B. Perry, DNP, PMHNP-BC, FNP-BC; Laura G. Leahy, DrNP, APRN, FAANP, FAAN

Disclosures:  The APNA planners and faculty have no relevant financial relationships to disclose. Off-label uses will be discussed during this presentation.

Session Length:  1 hour 45 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss three ways in which PMH nurses can assist patients in navigating the facts vs. myths related to GLP-1 receptor agonists to ensure appropriate use.

Key Takeaway(s): 

• GLP-1 agonists are currently indicated for the treatment of T2DM, Weight and CVD Risk but may have other applications.
• Compounded forms of GLP-1s lack efficacy and safety data and are largely unregulated, increasing safety concerns.
• Nurses can help patients who want to learn about, or are taking, GLP-1s by explaining the risks and benefits, supporting healthy behavioral changes, and helping them find reputable prescribers and suppliers.

Keywords:  GLP-1 Receptor Agonists, Medication Safety, Weight Management, Compounded Drugs

Nursing Continuing Professional Development:
1.75 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to the entire presentation, complete the reflection activity, evaluation, and honor statement before the expiration date. Once all steps are successfully completed, a certificate will be generated online and available for you to print immediately. Contact hours cannot be awarded unless all required components are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Release Date:  December 16, 2025
Access to this course will end:  December 1, 2027

*For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.